Crossmark

Systemic administration of quality- and quantity-controlled PBMNCs reduces bisphosphonate-related osteonecrosis of jaw-like lesions in mice

Published Online: 2019-07-16

Published Print: 2019-12

Authors

Kuroshima, Shinichiro https://orcid.org/0000-0001-9891-9987
Nakajima, Kazunori

Sasaki, Muneteru

I, Takashi

Sumita, Yoshinori

Asahara, Takayuki

Asahina, Izumi

Sawase, Takashi
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (25870523)

Japan Society for the Promotion of Science (15K11258)

Japan Society for the Promotion of Science (18H02994)

Japan Society for the Promotion of Science (16K20510)
License Information

Text and Data Mining valid from 2019-07-16

Version of Record valid from 2019-07-16
More Information

Article History

Received: 30 October 2018

Revised: 14 May 2019

Accepted: 19 June 2019

First Online: 16 July 2019

Ethics approval and consent to participate

: Animal care and experimental procedures were performed in accordance with the Guidelines for Animal Experimentation of Nagasaki University, with approval from the Ethics Committee for Animal Research (Approval No. 1708241404-2 and 1610181345-5).

: Not applicable

: The authors declare that they have no competing interests.

Document is current